Diffuse large B-cell lymphoma: open trials in Austria

• NCT06091865

  A Study to Compare How Well Odronextamab Combined With Chemotherapy Works and How Safe it is Against Rituximab Combined With Chemotherapy, in Adult Patients With Previously Untreated Diffuse Large B-cell Lymphoma

  Trial Treatment · Phase 3 · Regeneron Pharmaceuticals

  Medical University Graz, Graz · Landeskrankenhaus Hochsteiermark, Leoben · Kepler University Hospital, Linz · Hanusch-Krankenhaus, Vienna · Medical University of Vienna, Vienna · Klinikum Wels-Grieskirchen, Wels

  Registry updated 2026-11-04

• 2024-512320-11-00

  Age-adjusted high-dose chemotherapy followed by autologous stem cell transplantation or conventional chemotherapy with R-MP as first-line treatment in elderly primary CNS lymphoma patients – a randomized phase III trial - PRIMA-CNS

  Trial Treatment · Phase 3 · Medical Center - University Of Freiburg

  University Hospital Graz, Graz · Medizinische Universitaet Innsbruck, Innsbruck · Ordensklinikum Linz GmbH, Linz · Johannes Kepler University Linz, Linz

  Registry updated 2026-10-13

• NCT04844866

  Efficacy and Safety of MB-CART2019.1 vs. SoC in Lymphoma Patients

  Trial Treatment · Phase 2 · Miltenyi Biomedicine GmbH

  Medical University of Graz, Graz · Medizinische Universitaet Innsbruck, Innsbruck · Ordensklinikum Linz GmbH, Linz · Medical University of Vienna, Vienna

  Registry updated 2026-06-10

• NCT06830759

  Real-World Study to Assess Subcutaneous Epcoritamab in Adult Participants With Diffuse Large B-Cell and Follicular Lymphoma

  Research · AbbVie

  Krankenhaus Der Barmherzigen Brueder Graz /ID# 273288, Graz · Landeskrankenhaus Hochsteiermark, Standort Leoben /ID# 273266, Leoben

  Registry updated 2026-02-17

• NCT07066436

  ImmunoMRI for Assessment of Tumor-associated Macrophages

  Trial Treatment · Early phase 1 · Medical University of Vienna

  Medical University of Vienna, Vienna

  Registry updated 2025-07-15

All Diffuse large B-cell lymphoma trials and the map

This page is not medical advice. Talk to your doctor before contacting a trial.

Report an error